Is Fentanyl legal in Philippines?

Legal status

A dangerous drug under RA 9165. Fentanyl is printed as "60. FENTANYL" on page 7 of the Dangerous Drugs Board's Updated Lists of Scheduled Controlled Substances as at 06 July 2025, in its 1961 Schedule I section. It is also listed in the annex to RA 9165, which section 3(j) makes "an integral part of this Act". Fentanyl analogues and precursors carry their own separate entries.

Consequences if caught

Possession is section 11, measured "regardless of the degree of purity thereof". It falls in the limb for "other dangerous drugs such as" MDMA, PMA, TMA, LSD and GHB and "those similarly designed or newly introduced drugs and their derivatives, without having any therapeutic value or if the quantity possessed is far beyond therapeutic requirements": 10 grams or more carries life imprisonment and a fine of PHP 500,000 to PHP 10,000,000; 5 grams or more but less than 10 carries 20 years and 1 day to life imprisonment and a fine of PHP 400,000 to PHP 500,000; less than 5 grams carries 12 years and 1 day to 20 years and a fine of PHP 300,000 to PHP 400,000. These are penalty bands and not an allowance. For a medicine with therapeutic value the Act applies these bands where the drug is held without therapeutic value or in a quantity far beyond therapeutic requirements, as the Board determines; it states no separate band for an unauthorised quantity within therapeutic requirements, and none is asserted here. Section 13 imposes "the maximum penalties provided for in Section 11" on anyone found possessing a dangerous drug during a party, social gathering or meeting, or in the proximate company of at least two persons, "regardless of the quantity and purity", which is life imprisonment and a fine of PHP 500,000 to PHP 10,000,000. Importing or bringing a dangerous drug into the Philippines (section 4) and selling, giving away, delivering, distributing, transporting or brokering one (section 5) each carry life imprisonment and a fine of PHP 500,000 to PHP 10,000,000 "regardless of the quantity and purity involved", and manufacture (section 8) carries the same penalty. Each applies "unless authorized by law". Use is section 15: after a confirmatory test, a minimum of six months' rehabilitation in a government centre for a first offence, and 6 years and 1 day to 12 years with a fine of PHP 50,000 to PHP 200,000 for a second. RA 9165 prints "life imprisonment to death" in its penalty clauses, among them sections 4, 5, 8, 11 and 16. Republic Act No. 9346 of 24 June 2006 provides in section 1 that "The imposition of the penalty of death is hereby prohibited" and in section 2(b) substitutes life imprisonment where the law violated does not use the nomenclature of the Revised Penal Code, which RA 9165 does not. Section 98 of RA 9165 applies Revised Penal Code nomenclature to a minor offender, "reclusion perpetua to death", so for a minor RA 9346 section 2(a) substitutes reclusion perpetua. No drug offence carries death, and the fines set by RA 9165 are unchanged.

If prescribed or medical

Annex A to Board Regulation No. 1, Series of 2014 maps the 1961 Schedule I to Philippine Schedule 2. Section 31(6) of that Regulation allows a PDEA licensed practitioner to prescribe only FDA registered dangerous drugs, for up to 30 days' supply per prescription of a Schedule 2, 3 or 4 drug. Whether any product containing fentanyl is registered with the FDA was not checked for this cell. Board Regulation No. 10, Series of 2025, adopted 26 June 2025, authorizes an S2 licensed practitioner to use "ordinary prescriptions in prescribing any dangerous drug preparations", in three copies, to "effectively address the diseases, illnesses, infections, and symptoms associated with the global health concern on mpox; the regional increase in COVID19; and the local surge in HIV cases"; its section 9 kept it in force "until June 30, 2026", and it takes effect fifteen days after publication and registration. Board Regulation No. 5, Series of 2026, adopted 23 June 2026, extends it "until June 30, 2027" to relieve the "transportation, logistics, and financial burdens of obtaining special prescription forms", but takes effect only "upon its publication in two (2) newspapers of general circulation and its registration", dates the signed copy does not record, so whether the ordinary prescription route is in force today is not established. Board Regulation No. 8, Series of 2019, adopted 17 December 2019, provides a "License to Acquire, Possess, and Use Unregistered Drug Products Containing Dangerous Drugs for Personal Use", for drug products "currently unregistered or in the process of being registered with the FDA but are already registered in FDA reference countries". The patient, or a "parent, spouse, guardian, or relative within the fourth degree of consanguinity or affinity", applies to PDEA, and only for "Diseases covered by RA 10747 or the 'Rare Disease Act of the Philippines'", "Life-threatening and debilitating diseases", "Cancer and other terminal diseases", "Rare forms of neurological conditions", or "Other diseases with limited therapeutic options identified by the Department of Health". It takes effect fifteen days after publication and registration, dates the signed copy does not record. The International Narcotics Control Board's estimated requirement of the Philippines for fentanyl for 2026, April update, is 6,000 grams.

Documentation

A patient holding a licence under Board Regulation No. 8, Series of 2019 may bring an unregistered product in by "courier/parcel service or personal transport by patient or authorized family members", as that licence specifies. Otherwise, section 35 of Board Regulation No. 1, Series of 2014 lets a person under treatment who is entering, leaving or passing through the Philippines possess such quantities of a dangerous drug "as are reasonable for the purposes of such treatment", in the words of section 35(1) "wherever prescribed by a valid PDEA S2-licensed physician". The traveller carries a letter from the attending physician, the prescription with trade and generic names for up to 30 days' supply, and the medicine in its original labelled container. Above 30 days' supply the traveller needs certificates of authorization from the competent authority of the home country and from PDEA, requested from PDEA in writing 30 working days before arrival. Whether a prescription written abroad meets section 35(1) is not settled by its text, so confirm with PDEA before travelling. Without that authority the medicine is an imported dangerous drug under section 4 of RA 9165.

Drug laws and enforcement change and vary within a country. This is not legal advice. Always confirm with Philippines’s embassy or official drug authority before traveling; penalties can be severe, including imprisonment.